Skip to content
Blerp – Lifestyle
Author:
X4 Pharmaceuticals
X4 Pharmaceuticals to Participate in a Fireside Chat at the 2026 Wells Fargo Healthcare Conference
September 9, 2026
X4 Pharmaceuticals: FDA Agrees to Reduced Sample Size for Chronic Neutropenia Trial
September 8, 2026
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 1, 2026
X4 Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 6, 2026
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 3, 2026
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 7, 2026
X4 Pharmaceuticals Appoints Kelly Gold, Experienced Chief Financial Officer, to its Board of Directors
July 1, 2026
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 1, 2026
X4 Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference
May 27, 2026
X4 Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 6, 2026
1
2
Next Page
→